# Investigation of Potential Drug-drug Interactions Between Faldaprevir and the Immunosuppressant Drugs Cyclosporine or Tacrolimus

> **NCT02016625** · PHASE1 · COMPLETED · sponsor: **Boehringer Ingelheim** · enrollment: 32 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Faldaprevir
- **DRUG:** Faldaprevir
- **DRUG:** Cyclosporine
- **DRUG:** Tacrolimus

## Key facts

- **NCT ID:** NCT02016625
- **Lead sponsor:** Boehringer Ingelheim
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-12
- **Primary completion:** 2014-04
- **Final completion:** 2014-04
- **Target enrollment:** 32 (ACTUAL)
- **Last updated:** 2016-05-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02016625

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02016625, "Investigation of Potential Drug-drug Interactions Between Faldaprevir and the Immunosuppressant Drugs Cyclosporine or Tacrolimus". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT02016625. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*